Journal Article10.1002/14651858.cd009672.pub3
Hormone therapy for sexual function in perimenopausal and postmenopausal women
Lúcia Alves da Silva Lara,Denisse Cartagena-Ramos,Jaqueline BP Figueiredo,A.C.J.S. Rosa-e-Silva,Rui Alberto Ferriani,W. P. Martins,Miguel Fuentealba-Torres +6 more
10
TL;DR: Hormone therapy for sexual function in perimenopausal and postmenopausal women can improve sexual function and reduce associated symptoms.
read more
Abstract: The perimenopausal and postmenopausal periods are associated with many symptoms, including sexual complaints. This review is an update of a review first published in 2013.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Sexual health and wellbeing and the menopause: An EMAS clinical guide
Stavroula Α. Paschou,Kleoniki I. Athanasiadou,Trish Hafford‐Letchfield,Sharron Hinchliff,Melissa Mauskar,Margaret Rees,James A. Simon,Eleni Armeni,C. Tamer Erel,Ivan Fistonić,Timothy Hillard,Angelica Lindén Hirschberg,Błażej Męczekalski,Nicolás Mendoza,Alfred O. Mueck,Tommaso Simoncini,Petra Stute,Dorenda van Dijken,Ιrene Lambrinoudaki +18 more
TL;DR: This EMAS clinical guide emphasizes the importance of addressing sexual health and wellbeing in menopausal care, highlighting the need for healthcare providers to be trained in sexual health to provide optimal care and management.
2
Associations between arterial health and sexual function in women aged 60-64 years.
Viivi Virkkunen,Katja Kero,Mari Koivisto,Teemu J. Niiranen,Olli Tapio Heinonen,Sari Stenholm,Päivi Polo-Kantola +6 more
TL;DR: Associations between arterial health and sexual function in women aged 60-64 years are plausible, with higher diastolic blood pressure and ankle-brachial index being associated with higher sexual function.
1
Benefícios e indicações da terapia hormonal para mulheres na menopausa: Uma revisão integrativa de literatura
TL;DR: A terapia hormonal na menopausa é indicada para a maioria das mulheres que têm queixas relacionadas a essa fase da vida reprodutiva feminina, mas pode apresentar riscos à saúde.
1
Management of Vulvodynia
Martha Goetsch
TL;DR: Vulvodynia is a chronic vulvar pain condition lasting >6 months, with two subtypes: localized provoked vulvodynia (LPV) and vestibular vulvodynia, requiring multidisciplinary treatment approaches to address pain, intimacy, and emotional difficulties.
Management of sexual dysfunction in menopause: an update on evidence-based strategies
Giorgia E. Parrotta,Laura Cucinella,Rossella E. Nappi +2 more
TL;DR: A multidimensional approach integrating biological, psychological, and relational factors is essential for managing female sexual dysfunction (FSD) in menopause, requiring a proactive, structured clinical framework and open communication with healthcare providers.
References
Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
TL;DR: Synthetic conjugated estrogens B (0.3 mg/d) was effective in treating vulvovaginal atrophy in symptomatic postmenopausal women and significant improvement was seen in vaginal maturation index, vaginal pH, and severity of MBS from baseline to the end of treatment.
40
Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Tatiane Fernandes,Lúcia Costa-Paiva,Adriana Orcesi Pedro,Luiz Francisco Baccaro,Aarão Mendes Pinto-Neto +4 more
TL;DR: After a 12-week treatment with testosterone and estrogen compared with placebo lubrication, there was a significant improvement in vaginal trophism in postmenopausal women with vaginal atrophy.
40
The politics of sex research and constructions of female sexuality: what relevance to sexual health work with young women?
TL;DR: It is suggested that health care professionals need to develop an awareness of the diversities within female sexuality and gain insight into their own values and assumptions about female sexuality if these are not to inhibit effective approaches and interventions in the areas of HIV and sexual health.
40
Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
TL;DR: Tibolone may be an alternative to conventional hormone replacement therapy in the treatment of climacteric symptoms and sexual dysfunction in postmenopausal women.
40
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.
R. W. Rebar,J. Trabal,J. Mortola +2 more
TL;DR: Esterified estrogens 0.3 mg given daily provide adequate menopausal symptom relief and improved quality of life in postmenopausal women.
39